Caris Life Sciences vs Valthos AI Biodefense
Caris Life Sciences vs Valthos AI Biodefense, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Valthos AI Biodefense on 35/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 35/100
- agent readiness: 47/100 against 26/100
- domain rating: 62/100 against 30/100
- headcount: 1,659 against 11
- funding raised: $700M against $30.0M
- LinkedIn following: 77,698 against 2,901
Valthos AI Biodefense
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Valthos AI Biodefense |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Defense Tech, HealthTech, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 2008 | 2023 |
| Headquarters | Irving, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Valthos AI Biodefense |
|---|---|---|
| Employees | 1,659 | 11 |
| Open roles | Not published | 8 |
| Total funding | $700M | $30.0M |
| Latest round | Series D | Seed |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 2,901 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Valthos AI Biodefense |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 35/100 |
| Traction | 60/100 | Not published |
| Search visibility | 22/100 | Not published |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Valthos AI Biodefense |
|---|---|---|
| Hosting | Self Managed | Vercel |
| CDN | Not detected | Vercel |
| CMS | WordPress | Not detected |
| Frameworks | Not detected | Next.js, Tailwind CSS |
| Analytics | Google Tag Manager | Not detected |
Caris Life Sciences vs Valthos AI Biodefense: common questions
Which is better, Caris Life Sciences or Valthos AI Biodefense?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Valthos AI Biodefense compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 35/100), agent readiness (47/100 against 26/100), domain rating (62/100 against 30/100), headcount (1,659 against 11), funding raised ($700M against $30.0M), LinkedIn following (77,698 against 2,901).
Read the full Caris Life Sciences review and pricing or the Valthos AI Biodefense review and pricing. You can also browse other Caris Life Sciences alternatives we track.